Company Details, Financials & Peer Comparison
Skip Navigation LinksHome > Research Reports
 
ArrowResearch Reports
Special Report
Angel PDF Market Strategy - Diwali Special
 
Market Outlook Market Outlook
Technical Report Technical Report
Derivative Report Derivative Report
Weekly Report Weekly Report
Stock Holding Disclosure Stock Holding Disclosure
Find Research Reports by Company Name
View Research Archives Side Arrow View Archives Side Arrow
Equity Fundamental Research Reports

Equity Fundamental Research Reports

Abbott India Ltd : 22/11/2014
Result Updates CMP : 3405 Target Price : 3711 Recommendation : Accumulate
For 2QFY2015, Abbott India (AIL) reported a good set of results. Its top-line grew by 28.9% yoy to Rs589cr. Although the raw material cost as a percentage of sales increased marginally by 47bp yoy t....
More      
State Bank of India : 19/11/2014
Result Updates CMP : 2940 Target Price : 3265 Recommendation : Accumulate
For 2QFY2015, State Bank of India (SBI) reported a PAT growth of 30.5% yoy to Rs3,100.4cr, mainly on account of 14.9% yoy growth in operating income and lower opex growth of 2.2% yoy. SBIs Asset qua....
More      
Visaka Industries Ltd : 18/11/2014
Result Updates CMP : 123 Target Price : 174 Recommendation : Buy
Visaka Industries (VIL) is engaged in two businesses – building products (cement asbestos products and fibre cement flat products like V-boards and V-panels) and synthetic yarn. It has an installed ....
More      
Eicher Motors Ltd : 18/11/2014
Result Updates CMP : 13833 Target Price : 15654 Recommendation : Accumulate
Eicher Motors Ltd (EML)s 3QCY2014 results were in line with our estimates on the operating front; however lower other income and higher taxation led to lower than expected profits. The demand for Ro....
More      
Dishman Pharmaceuticals and Chemicals Ltd : 17/11/2014
Result Updates CMP : 139 Target Price : 217 Recommendation : Buy
For 2QFY2015, Dishman Pharmaceuticals and Chemicals (Dishman) posted results better than our expectations on the sales front, while it disappointed on the OPM front, while the net profit was margina....
More      
Sun Pharmaceuticals Industries Ltd : 14/11/2014
Result Updates CMP : 909 Target Price : Recommendation : Neutral
For 2QFY2015, Sun Pharmaceuticals Industries (Sun Pharma) posted sales of Rs4,751cr (V/s an expected Rs4,737cr), a yoy growth of 13.3%, driven by domestic markets which grew by 21.3% yoy. On the ope....
More      
Cipla Ltd : 14/11/2014
Result Updates CMP : 624 Target Price : Recommendation : Neutral
Ciplas 2QFY2015 results have come in below expectations on all fronts. For the period, the company posted sales of Rs2,630cr (V/s an expected Rs2,889cr), a growth of 5.9% yoy. On the operating front....
More      
Ipca Laboratories Ltd : 14/11/2014
Result Updates CMP : 669 Target Price : 817 Recommendation : Buy
IPCA Laboratories results for 2QFY2015 have come in below our expectations. It posted sales of Rs775cr (below our expectation of Rs876cr for the quarter, ie a de-growth of 7.6% yoy, on back of impac....
More      
Sanofi India Ltd : 14/11/2014
Result Updates CMP : 3451 Target Price : 3700 Recommendation : Accumulate
Sanofi India (Sanofi)s 3QCY2014 results have come in below expectations both on the top-line and bottom-line front. The company posted sales of Rs487cr (V/s an expected Rs530cr), ie a yoy growth of ....
More      
Goodyear India Ltd : 14/11/2014
Result Updates CMP : 631 Target Price : 830 Recommendation : Buy
For 3QCY2014, Goodyear India (GIL) reported a mixed set of numbers. The top-line for the quarter declined marginally by 1.2% yoy to Rs402cr, below our expectation of Rs431cr. The raw material cost a....
More      
Ashok Leyland Ltd : 10/11/2014
Result Updates CMP : 49 Target Price : 55 Recommendation : Accumulate
Ashok Leyland (ALL)s 2QFY2015 results have come in in line with our estimates on the operating front; however higher taxation dragged the profitability. ALLs MHCV volumes have rebounded sharply in ....
More      
Glaxosmithkline Pharma Ltd : 10/11/2014
Result Updates CMP : 2793 Target Price : Recommendation : Neutral
GlaxoSmithKline Pharmaceuticals 3QCY2014 results came in better than expected. The revenue for the quarter grew by 19.1% yoy to Rs739cr, better than our expectation of Rs670cr. On the operating front,....
More      
Aurobindo Pharma Ltd : 10/11/2014
Result Updates CMP : 1031 Target Price : Recommendation : Neutral
Aurobindo Pharma (APL) announced a decent set of numbers for 2QFY2015. The revenue for the quarter grew by 50.8% yoy to Rs2,862cr, in line with our expectation of Rs2,895cr. On the operating front, ....
More      
Cadila Healthcare Ltd : 10/11/2014
Result Updates CMP : 1490 Target Price : Recommendation : Neutral
Cadila Healthcare (Cadila) announced a decent set of numbers for 2QFY2015. Its revenue for the quarter grew by an impressive 21.5% yoy to Rs2,064cr, almost in line with our expectation of Rs2,020cr.....
More      
TVS Srichakra Ltd : 10/11/2014
Result Updates CMP : 1206 Target Price : 1645 Recommendation : Buy
For 2QFY2015, TVS Srichakra (TVSSL) reported a better-than-expected set of numbers. Its top-line grew by 18.5% on a yoy basis to Rs491cr, ahead of our estimate of Rs473cr. The operating margin expan....
More      
Fundamental Analysis Approach to Fundamental Research
Technical Analysis Approach to Technical Research
Angel eye
FAQ | Investor Education | Terms of Use | Miscellaneous | Important Documents | Feedback | Careers | Sitemap